指南与共识免疫规划卫生政策与健康促进

嗅觉丧失:Brighton协作组病例定义及免疫接种安全性数据收集、分析和呈现指南

Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
指南 / 共识 · Vaccine · 2023-02-10

Brighton协作组在流行病防范创新联盟(CEPI)支持下,经文献 exhaustive 回顾和专家咨询制定嗅觉丧失的共识性病例定义及确定度分级,用于评估免疫接种后不良事件及流行病学背景发病率研究或假设检验;文件经Brighton协作网络同行评议及两位专家审阅后提交。

要点

  • 该病例定义由CEPI召集的专家组制定,用于免疫接种后不良事件评估。
  • 定义包含确定度分级,遵循Brighton协作组共识格式。
  • 适用于背景发病率评估或假设检验的流行病学研究。

核心结论

  • 该文件提供嗅觉丧失的Brighton协作组病例定义及数据收集、分析、呈现指南,用于免疫接种安全性评估和流行病学研究。

研究设计与样本

  • 制定机构为流行病防范创新联盟(CEPI)召集的专家组,遵循Brighton协作组病例定义格式,经 exhaustive 文献回顾和专家咨询形成共识定义及确定度分级,并经Brighton协作网络同行评议和两位专家审阅。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This is a Brighton Collaboration case definition of anosmia to be used in the evaluation of adverse events following immunization, and for epidemiologic studies for the assessment of background incidence or hypothesis testing. The case definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of SARS-CoV-2 vaccines. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by two expert reviewers prior to submission.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Liu YC, Munoz FM, Izurieta HS, et al. Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2023. PMID: 36775774. doi:10.1016/j.vaccine.2022.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。